Cullinan Oncology
CGEM
106 hedge funds and large institutions have $344M invested in Cullinan Oncology in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 33 increasing their positions, 31 reducing their positions, and 13 closing their positions.
6% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 31
0% more funds holding
Funds holding: 106 → 106 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
4.77% less ownership
Funds ownership: 93.7% → 88.93% (-4.8%)
13% less capital invested
Capital invested by funds: $397M → $344M (-$53.3M)
86% less call options, than puts
Call options by funds: $80K | Put options by funds: $560K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$5.8M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$5.02M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.87M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.78M |
| 5 |
BlackRock
New York
|
+$1.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.53M |
| 2 |
AG
Artal Group
Luxembourg
|
-$2.69M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$2.48M |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$1.24M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$901K |
CGEM Hedge Fund Activity: Q3 2023 in Review
106 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q3 2023, worth a combined $344M — down 13% from $397M a quarter earlier.
Fund positioning in CGEM was balanced in Q3 2023: 13 funds opened new positions, 13 closed out, 33 added to existing stakes and 31 trimmed.
The largest buyer was Franklin Resources, adding an estimated $5.8M. The largest seller was Vanguard Group, cutting an estimated $3.53M.
- 106 institutional investors held Cullinan Oncology (CGEM) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $344M of Cullinan Oncology stock for Q3 2023, down 13% quarter-over-quarter.
- 13 funds opened new Cullinan Oncology positions in Q3 2023 and 13 closed out, a net change of 0 holders.
- The largest Cullinan Oncology buyer in Q3 2023 was Franklin Resources, an estimated $5.8M added.
- The largest Cullinan Oncology seller in Q3 2023 was Vanguard Group, an estimated $3.53M sold.
Based on aggregated 13F filings for Q3 2023.